The rate of virological failure was assessed in 819 patients followed up by the private sector
of Douala, the economic capital of Cameroon, and treated according to the World Health …

The rate of virological failure was assessed in 386 adult patients attending the Centre
National Hospitalier Universitaire of Bangui, the capital city of the Central African Republic …

Objective To describe changes in plasma viral load, CD4+ cell counts, and drug resistance
profiles of HIV-2-infected patients receiving antiretroviral (ARV) therapy in Abidjan, Côte …

Objective To determine the prevalence of genotypic and phenotypic antiretroviral (ARV)
drug-resistant HIV-1 strains among patients with viral load rebound while receiving ARV …

Background With widespread use of antiretroviral (ARV) drugs in Africa, one of the major
potential challenges is the risk of emergence of ARV drug‐resistant HIV strains. Our …

Background More than 15 million people in sub-Saharan Africa receive ART. Treatment
failure is common, but the role of HIV drug resistance in treatment failure is largely unknown …

Methods In a prospective cohort study, 300 consecutive patients starting first‐line ART were
enrolled between 2009 and2010 in a large HIV treatment centre in rural Cameroon. Patients …

Introduction The current expansion of antiretroviral treatment (ART) in the developing world
without routine virological monitoring still raises concerns on the outcome of the strategy in …

Abstract Introduction: In Tanzania, the follow-up on antiretroviral therapy (ART) response is
based on clinical outcomes. We investigated virological response and ARV resistance …

Background: We assessed risk factors for viremia and drug resistance among long-term
recipients of antiretroviral therapy (ART) in South Africa. Methods: In 2008, we conducted a …